Cite
HARVARD Citation
Li, J. et al. (2017). Population pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer. British journal of clinical pharmacology. pp. 1723-1733. [Online].